Analyst Price Targets — PH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 24, 2026 1:33 pm | — | Morgan Stanley | $1,038.00 | $1,018.77 | TheFly | Parker-Hannifin price target raised to $1,038 from $945 at Morgan Stanley |
| January 30, 2026 2:54 pm | — | Truist Financial | $1,139.00 | $936.20 | TheFly | Parker-Hannifin price target raised to $1,139 from $1,097 at Truist |
| January 30, 2026 12:39 pm | — | KeyBanc | $1,100.00 | $948.40 | TheFly | Parker-Hannifin price target raised to $1,100 from $1,050 at KeyBanc |
| January 30, 2026 12:37 pm | — | Stifel Nicolaus | $965.00 | $948.40 | TheFly | Parker-Hannifin price target raised to $965 from $941 at Stifel |
| January 30, 2026 12:36 pm | — | Robert W. Baird | $1,050.00 | $948.40 | TheFly | Parker-Hannifin price target raised to $1,050 from $960 at Baird |
| January 30, 2026 10:32 am | — | Barclays | $1,020.00 | $948.40 | TheFly | Parker-Hannifin price target raised to $1,020 from $990 at Barclays |
| January 29, 2026 10:19 pm | — | Industrial Alliance Securities | $1,032.00 | $948.40 | TheFly | Parker-Hannifin price target raised to $1,032 from $1,000 at Goldman Sachs |
| January 23, 2026 1:36 pm | — | Stifel Nicolaus | $941.00 | $932.70 | TheFly | Parker-Hannifin price target raised to $941 from $869 at Stifel |
| January 14, 2026 2:08 pm | Christopher Snyder | Morgan Stanley | $945.00 | $931.66 | TheFly | Parker-Hannifin price target raised to $945 from $725 at Morgan Stanley |
| January 7, 2026 11:44 am | — | Barclays | $990.00 | $928.76 | TheFly | Parker-Hannifin price target raised to $990 from $950 at Barclays |
Latest News for PH
DNB Asset Management AS reduced its stake in Parker-Hannifin Corporation (NYSE: PH) by 12.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,265 shares of the industrial products company's stock after selling 7,014 shares during the period. DNB Asset
Aster Capital Management DIFC Ltd purchased a new position in shares of Parker-Hannifin Corporation (NYSE: PH) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,569 shares of the industrial products company's stock, valued at approximately $1,190,000. A number of other
MONTREAL, Feb. 25, 2026 (GLOBE NEWSWIRE) -- 35Pharma, a Canada-based, private, clinical-stage biopharmaceutical company specialised in the development of novel protein-based therapeutics today announced it has entered into an agreement with GSK plc (GSK), under which GSK will acquire all of the outstanding equity interests in 35Pharma. The acquisition includes HS235, a potential best-in-class investigational…
Does Parker-Hannifin (PH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Dana Investment Advisors Inc. lessened its holdings in shares of Parker-Hannifin Corporation (NYSE: PH) by 15.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 23,366 shares of the industrial products company's stock after selling 4,358 shares during the period. Dana
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.